| Document |
Document Title |
|
WO/2005/030317 |
A method for treating an inflammation in skin of a patient includes irradiating the skin with infrared (IR) radiation in a first wavelength band and with violet/blue light in a second wavelength band with an apparatus radiating both wave...
|
|
WO/2005/030329 |
A method of damaging biomolecules which enhances the efficiency of biomolecule damaging (cleavage) by photosensitized one-electron oxidation reaction; and an apparatus for carrying out this method. Thus, there can be realized a method of...
|
|
WO/2005/030253 |
The present invention provides visible light sensitive and ultraviolet (UV) light sensitive composition for DNA transfer comprising acid sensitive polyacetals developed as DNA/RNA delivery agents, a photoacid generator and optionally a p...
|
|
WO/2005/025508 |
The invention relates to magnetically targetable particles comprising at least one magnetic component. The particles are capable of delivering selectively to a site or organ a biologically active substance for in vivo medical diagnosis a...
|
|
WO/2005/023096 |
In some aspects, there are provided compositions and kits including annexin coupled to ultrasound contrast particles as well as methods utilizing these particles for diagnosis and treatment of pathological conditions characterized by apo...
|
|
WO/2005/023220 |
A pharmaceutical liposomal formulation for photodynamic therapy comprising a non-polar porphyrin photosensitizer and one or more phospholipids, which are stable in storage without requiring freeze-drying is described. The liposomal formu...
|
|
WO/2005/021094 |
A method and composition for destroying microbes, especially bacteria, in the body utilizing Safranin O in conjunction with electromagnetic radiation is disclosed. In a preferred method, a composition comprising Safranin O is introduced ...
|
|
WO/2005/020918 |
Methods, compositions and apparatus for localized delivery of compounds are provided. In certain embodiments, radiation force is used to direct carriers to a target site, and additional radiation is used to fragment the localized carrier...
|
|
WO/2005/020918 |
Methods, compositions and apparatus for localized delivery of compounds are provided. In certain embodiments, radiation force is used to direct carriers to a target site, and additional radiation is used to fragment the localized carrier...
|
|
WO/2005/016369 |
Methods of treating cancer and/or reducing or inhibiting tumor growth in a subject in need thereof, comprising administering pharmaceutical composition comprising a vascular endothelial cell growth factor (VEGF) inhibitor or trap, such a...
|
|
WO/2005/017522 |
As per invention embodiment, the method provides Deuterium Depleted Water administering to tested animals before and after tumoral grafting with animal grafts and it takes the following steps: A) Deuterium Depleted Water administering to...
|
|
WO/2005/014003 |
The present invention relates to the use of the alkaloid K252 and its analogues or derivatives to prepare topical drugs for the treatment of disorders characterised by hyperproliferation of keratinocytes.
|
|
WO/2005/014019 |
The invention relates to medicine and can be used for scientific and practical activity, including the treatment of different human and animal diseases. The inventive composition consists of food products and extracts of medicinal plants...
|
|
WO/2005/014572 |
Pyrimidylpyrrole derivatives of formula (1) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the...
|
|
WO/2005/011810 |
Magnetic particles are used in therapeutic applications to disrupt a biological material. The particles have intrinsic magnetization, said magnetization being stabilised by inherent magneto-crystal line anisotropy and/or by shape anisotr...
|
|
WO/2005/011752 |
This invention relates to the sterilization of polymeric material by irradiation for use in a body of a mammal. The sterilization of polymeric materials for use in a mammal by irradiation is improved by reducing the temperature at which ...
|
|
WO/2005/007837 |
Extracellular material obtained from skeletal cells may be used in the stimulation of new bone production. The active extracellular material may be derived from cultures of immortalised hypertrophic chondrocyte-like cells. The invention ...
|
|
WO/2005/004872 |
The present invention elates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularl...
|
|
WO/2005/004972 |
Disclosed is a device for penetrating a skin active agent to the human body via the skin by the use of an ultrasoundapplying apparatus which applies ultrasound to the human body via the skin, comprising: (1) composition comprising: (a) s...
|
|
WO/2005/004781 |
A non-invasive method for disrupting a blood clot within the vasculature of a patient using new ultrasound techniques is provided. Lipid vesicles containing a gas or gaseous precursor are administered intravascularly to the patient and u...
|
|
WO/2005/004790 |
The invention relates to ark organic, chemical liquid massage composition used in the cure of anatomic diseases like joint hernia, calcification, joint circulation disorders, rheumatic arthritis, osteo arthritis and the functional muscul...
|
|
WO/2005/004870 |
The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particular...
|
|
WO/2005/004720 |
Some embodiments include a ring anode (42) to emit radiation, and a conical monochromator (60) to monochromatize the emitted radiation. According to some aspects, an outer diameter of the ring anode is greater than an outer diameter of a...
|
|
WO/2005/000352 |
The present invention generally relates to the reduction of the harmful effects of orally or transdermally delivered nicotine in conventional tobacco-use cessation programs. More specifically, embodiments concern methods of reducing the ...
|
|
WO/2005/000341 |
The present invention relates to the reduction of tumor growth. More specifically, the present invention relates to the use of cytosolic phospholipid hydroperoxide glutathione peroxidase (cPHGPx) to reduce tumor growth. Moreover, the pre...
|
|
WO/2004/112708 |
Methods and devices for the regulation of matrix metalloproteinase gene expression in cartilage cells via the application of fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or ...
|
|
WO/2004/112590 |
The present invention provides methods of using metal nanoparticles 0.5 to 400 nm in diameter to enhance the dose and effectiveness of x-rays or of other kinds of radition in therapeutic regimes ob ablating a target tissue such as tumor....
|
|
WO/2004/110151 |
The present invention relates to a method for treating cancer in an animal by administering to the animal an active vitamin D compound in combination with a radiotherapeutic agent or treatment.
|
|
WO/2004/110438 |
The invention relates to the pharmaceutical industry and can be used in medicine for diagnosis and curing malignant neoplasms of skin, mucous tunics and genital organs. The essence of said invention lies in an agent for photodynamic diag...
|
|
WO/2004/110255 |
The present invention relates to novel antineoplastic agents and cancer diagnostic agents that specifically target neoplastic cells via the GLUT transportation system. More specifically, the invention relates to conjugates of 2-deoxygl...
|
|
WO/2004/108919 |
The present invention relates to biological compositions and dietary supplement comprising yeast cells that can produce a healthful benefit in a subject inflicted with cancer. The biological compositions can be used to retard the growth ...
|
|
WO/2004/103274 |
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory...
|
|
WO/2004/101516 |
Disclosed herein are novel trisulfonated tribenzo-mononahptho-porphyrazines, processes for making them and their application as improved photosensitizing drugs for the treatment of various medical conditions by photodynamic therapy (PDT)...
|
|
WO/2004/101003 |
The invention relates to a method for eliminating microorganisms (10), particularly bacteria, viruses, monocellular or multicellular life forms, individual cells or the like, during which the microorganisms (10) are subjected to the acti...
|
|
WO/2004/099375 |
The present invention relates to indirectly linked photosensitizer immunoconjugate (PIC) compositions, methods of preparation and the use of the same in photodynamic therapeutic and diagnostic applications. PICs comprising a photosensiti...
|
|
WO/2004/098629 |
The present invention relates to GnRH conjugates comprising a GnRH analog coupled to a photosensitizer and to pharmaceutical compositions comprising same. The conjugates of the invention bind to GnRH receptors with high affinity and exhi...
|
|
WO/2004/099375 |
The present invention relates to indirectly linked photosensitizer immunoconjugate (PIC) compositions, methods of preparation and the use of the same in photodynamic therapeutic and diagnostic applications. PICs comprising a photosensiti...
|
|
WO/2004/096190 |
Disclosed is a composition including magnetic nanoparticles each of which encapsulates a magnetic material and a drug with a biodegradable synthetic polymer. Also, the present invention discloses a method of preparing the magnetic nanopa...
|
|
WO/2004/096206 |
The present invention provides compositions and methods to treat, prevent or inhibit a neoplasia, a neoplasia-related disorder, pain, inflammation, an inflammatory-related disorder, a vaso-occlusive event or a vaso-occlusive-related diso...
|
|
WO/2004/093856 |
The present invention provides compositions and methods to treat, prevent or inhibit a neoplasia or a neoplasia-related disorder in a mammal using a combination of a COX-2 inhibitor and an alkylating-type antineoplastic agent.
|
|
WO/2004/093868 |
The present invention provides compositions and methods to treat, prevent or inhibit a neoplasia, a neoplasia-related disorder or osteoporosis in a mammal using a combination of a COX-2 inhibitor and an aromatase inhibitor.
|
|
WO/2004/091629 |
Methods for preventing damage to the epidermis during PDT induced using a pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control formation of a photoactive species from a topi...
|
|
WO/2004/091531 |
Methods for preventing damage to epithelial tissue during PDT induced using a photosensitizing agent or pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control photoactivation ...
|
|
WO/2004/092115 |
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associ...
|
|
WO/2004/091592 |
Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introductio...
|
|
WO/2004/089356 |
The invention provides a method of inhibiting cell death in a mammal. The method comprises administering to a mammal an effective amount of a composition comprising a cell protection factor preferred a temporary p53 inhibitor such as pif...
|
|
WO/2004/089300 |
The present invention relates to compounds of Formula (I): their pharmaceutical composition and their utility in treating neoplasm.
|
|
WO/2004/089409 |
The invention relates to an agent for the photodynamic diagnosis and therapy of oncological diseases, which is based on chlorin E6 compounds, and novel medicinal uses of chlorin E6 compounds.
|
|
WO/2004/087765 |
A titanium dioxide complex capable of distinguishing molecules is obtained by modifying the surface of a fine titanium dioxide particle with a hydrophilic polymer in such a manner that titanium dioxide is bonded via an ester bond to a ca...
|
|
WO/2004/087103 |
The current situation is such that it is difficult for drugs to reach posterior tissues of eyeball, such as choroid and retina, with the result that treating diseases in such regions is difficult. Thus, how to attain effective delivery o...
|
